HCL Technologies Ltd vs Hindustan Bio Sciences Ltd
A side-by-side comparison of HCL Technologies Ltd (HCLTECH) and Hindustan Bio Sciences Ltd (HINDBIO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, HCL Technologies Ltd leads HCLTECH vs HINDBIO on 13 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Stock is providing a good dividend yield of 4.49%.", "Company has been maintaining a healthy dividend payout of 90.6%"]
- − ["The company has delivered a poor sales growth of 11.5% over past five years."]
- + ["Debtor days have improved from 125 to 24.7 days."]
- − ["Stock is trading at 8.78 times its book value", "Company has low interest coverage ratio.", "The company has delivered a poor sales growth of -6.40% over past five years.", "Promoter holding is low: 12.2%", "Company has a low return on equity of 3.21% over last 3 years.", "Company might be capitalizing the interest cost"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.